20 July 2020 at 4:00pm

The seminar will be conducted via Zoom
LKS Faculty of Medicine Building, 21 Sassoon Road, Hong Kong

https://hku.zoom.us/j/94315557020

Meeting ID: 943 1555 7020

22 June 2020 at 10:00 (HK Time)

Ms. SHAO Zitong
“Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats”

Ms. WEI Yue
“20‐year follow‐up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)"

Ms. WONG Si Nga
“Pharmaceutical Cocrystals: Formulation Approaches to Develop Robust Drug Products"

Mr. CHEUNG Wing Ming
“Distinct signaling and transcriptional pathways regulate peri-weaning development and cold-induced recruitment of beige adipocytes"

18 June 2020 at 10:00 (HK Time)

Ms. GE Mengqin
“Maternal thyroid function during pregnancy and child brain morphology: a time window-specific analysis of a prospective cohort”

Mr. LIU Wenjing
“Hydroxytyrosol NO regulates oxidative stress and NO production through SIRT1 in diabetic mice and vascular endothelial cells"

Mr. LONG Kaiqi
“The entry of nanoparticles into solid tumours"

Ms. WONG Wing Yin
“Use of Glucagon-Like Peptide 1 Receptor Agonists and Risk of Serious Renal Events: Scandinavian Cohort Study"

15 June 2020 at 09:15

 09:15
“High-dose Versus Low-dose Statins for Primary Prevention of Cardiovascular Events”
by Mr. BLAIS Joseph

09:35
“Short-term High Fat Diet Mitigates Radiation-induced Intestinal Injury Through Gut Microbiota”
by Ms CAI Jieling

09:55
“Role of SIRT1 in Mediating the Anti-contractile Activity of Perivascular Adipose Tissues”
by Mr. KONIA Daniels

10:15
“Investigation of Adipocyte Progenitors Expressing Lipocalin-2”
by Ms LI Dahui

10:35
“Intravenous Chemotherapy of Retinoblastoma via Green-light-triggered Drug Release”
by Mr. LONG Kaiqi

10:55
“Effects of Compound 21, FPMINT Derivative on Human Equilibrative Nucleoside Transporters”
by Mr. MAK Wing Shum

11:15
“Delivery of siRNA Targeting Epidermal Growth Factor Receptor (EGFR) and Programmed Death Ligand 1 (PD-L1) as a Therapeutic Strategy Against Non-small-cell Lung Cancer (NSCLC)”
by Mr. MAN Chi Hang

11:35
“Optimization of KL4 Peptide with PEGylation Strategy for Pulmonary Delivery of siRNA”
by Ms QIU Yingshan

11:55
“Screening of Novel Triazole Coerystal for Managing Respiratory Infections”
by Ms WONG Si Nga

12:15
“Facilitators and Barriers to the Applications of Machine Learning in Evidence-based Medicine”
by Mr. HSU Warrington Wen Qiang

12:35
“Polymorph Screening and Preparation Through Attaining High Drug Supersaturation by Solubility Advantage of Cocrystals”
by Ms XUAN Bianfei

12:55
“Ultrasound-triggered Drug Release from Polymersomes for Retinoblastoma Therapy”
by Ms ZHANG Yaming

11 June 2020 at 10:00 (HK Time)

Ms. CAI Jieling
“Cyclase-associated Protein 1 Is a Binding Partner of Proprotein Convertase Subtilisin/Kexin type-9 and Is Required for the Degradation of Low-Density Lipoprotein Receptors by Proprotein Convertase Subtilisin/Kexin type-9”

Mr. CHENG Wing Tak
“Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants on hemodialysis"

Mr. HSU Wen Qiang
“Association Rules Method and Big Data: Evaluating Frequent Medication Combinations Associated With Fractures in Older Adults"

Mr. PAN Harry Weijie
“Respiratory Administration of Infliximab Dry Powder for Local Suppression of Inflammation"